CVA Family Office’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

CVA Family Office’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$528	–	1481
2025 Q1	$528	Buy	+4	New	+$498	﹤0.01%	1240

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CVA Family Office's ITCI Position: Q2 2025 in Review

CVA Family Office sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 4 shares — an estimated $528 sold.

CVA Family Office first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $528 in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

CVA Family Office reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
CVA Family Office sold 4 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $528.
CVA Family Office first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
CVA Family Office's Intra-Cellular Therapies Inc. position peaked at $528 in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on CVA Family Office's 13F filing for Q2 2025, filed 31 Jul 2025.